Showing results (1461-1470 of 1,745) with videos related to
Sort By:
Pageof 175
Vnitrni Lekarstvi|March 25, 2010
[Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review]Z Adam, K Balsíková, M Krejcí, et al.Diabetologia|November 27, 2010
Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youthD Dabelea, L M Dolan, R D'Agostino, et al.Nutrients|August 2, 2019
Body Mass Index Z-Score Modifies the Association between Added Sugar Intake and Arterial Stiffness in Youth with Type 1 Diabetes: The Search Nutrition Ancillary StudyNatalie S The, Sarah C Couch, Elaine M Urbina, et al.Leukemia|June 12, 2013
The EUTOS prognostic score: review and validation in 1288 patients with CML treated frontline with imatinibV S Hoffmann, M Baccarani, D Lindoerfer, et al.The American Journal of Clinical Nutrition|January 1, 1997
Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance Atherosclerosis Study (IRAS)E J Mayer-Davis, J H Monaco, H M Hoen, et al.Acta Medica Austriaca|June 8, 2002
Interleukin-2 activation of haematopoietic stem cellsR Hájek, Z Korístek, J Vinklárková, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 8, 2007
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancerJ A Meyerhardt, K Stuart, C S Fuchs, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 1999
Patients with t(8;21)(q22;q22) and acute myeloid leukemia have superior failure-free and overall survival when repetitive cycles of high-dose cytarabine are administeredJ C Byrd, R K Dodge, A Carroll, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)Nancy E Kemeny, Donna Niedzwiecki, Donna R Hollis, et al.JAMA|June 28, 2007
Incidence of diabetes in youth in the United States, Dana Dabelea, Ronny A Bell, et al.Pageof 175